Skip to main content

Table 7 Distribution of difficulty in swallowing, difficulty in speech, cheek flexibility according to group in different time periods

From: Effectiveness of Pentoxifylline in the treatment of oral submucous fibrosis patients: a case-control study

 

Group

N

Mean Rank

Sum of Ranks

U value

P value

DIFFICULTY IN SWALLOWING

Baseline

Pentoxyfylline

40

32.50

1040.00

  

Placebo

40

32.50

1040.00

0.000

1.000

Total

80

    

1st Month

Pentoxyfylline

40

32.00

1024.00

  

Placebo

40

33.00

1056.00

0.587

0.558

Total

80

    

2nd Month

Pentoxyfylline

40

32.00

1024.00

  

Placebo

40

33.00

1056.00

0.587

0.558

Total

80

    

3rd Month

Pentoxyfylline

40

32.00

1024.00

  

Placebo

40

33.00

1056.00

0.587

0.558

Total

80

    

Baseline

Pentoxyfylline

40

32.50

1040.00

  

Placebo

40

32.50

1040.00

0.000

1.000

Total

80

    

1st Month

Pentoxyfylline

40

32.50

1040.00

  

DIFFICULTY IN SPEECH

Placebo

40

32.50

1040.00

0.000

1.000

Total

80

    

2nd Month

Pentoxyfylline

40

32.50

1040.00

  

Placebo

40

32.50

1040.00

0.000

1.000

Total

80

    

3rd Month

Pentoxyfylline

40

32.50

1040.00

  

Placebo

40

32.50

1040.00

0.000

1.000

Total

80